Regulatory T cells (Tregs), epiplakin1 [42] and neuropilin and tolloid-like 2 (NETO2) [43] reduce the radiosensitivity of ESCC by activating the EMT and PI3K/AKT pathways. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.